Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 22;22(3):327.
doi: 10.3390/ijerph22030327.

Homozygous AA Genotype of IL-17A and 14-bp Insertion Polymorphism in HLA-G 3'UTR Are Associated with Increased Risk of Gestational Diabetes Mellitus

Affiliations

Homozygous AA Genotype of IL-17A and 14-bp Insertion Polymorphism in HLA-G 3'UTR Are Associated with Increased Risk of Gestational Diabetes Mellitus

Amaxsell Thiago Barros de Souza et al. Int J Environ Res Public Health. .

Abstract

Gestational diabetes mellitus (GDM) is a common pregnancy complication characterized by hyperglycemia and insulin resistance, with unclear genetic mechanisms. The specific involvement of proinflammatory cytokines, including IL-17A, and the immuno-tolerogenic HLA-G remains poorly understood in GDM. We aimed to explore the associations of three polymorphisms, IL-17A -197G>A (rs2275913), IL-17RA -947A>G (rs4819554), and HLA-G 14-bp insertion/deletion (indel), with GDM risk in a Brazilian population. We conducted a case-control study (79 GDM cases and 79 controls). Genetic polymorphisms were analyzed using PCR-RFLP, with DNA extracted using the Salting-out procedure. Significant associations were identified between -197G>A rs2275913 and HLA-G 14-bp indel polymorphisms in both codominant and recessive models. The IL-17A rs2275913 AA genotype was associated with a nearly ten-fold increased risk of GDM in both the codominant (p = 0.021, OR 9.89, 95% CI: 1.63-59.92) and recessive models (p = 0.006, OR 9.33, 95% CI: 1.57-55.38). Similarly, the HLA-G 14-bp Ins/Ins genotype was associated with an increased risk in both the codominant (p = 0.026, OR 3.34, 95% CI: 0.98-11.41) and recessive models (p = 0.010, OR 4.20, 95% CI: 1.36-12.96). IL-17RA polymorphism showed no significant associations. The study findings highlight the potential genetic and immune factors associated with GDM, particularly the -197G>A rs2275913 and HLA-G 14-bp indel polymorphisms. Further functional characterization is warranted to uncover the mechanism of genotype-phenotype association.

Keywords: Gestational Diabetes Mellitus; HLA-G 14-bp insertion/deletion; IL-17A polymorphism; IL-17RA polymorphism; genetic association.

PubMed Disclaimer

Conflict of interest statement

The authors Juliana Dantas de Araújo Santos Camargo and Ricardo Ney Cobucci are employed by Brazilian Company of Hospital Services (EBSERH). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Mechanism of action of the SNPs IL-17A -197G>A rs2275913 and HLA-G 3′UTR 14-bp Insertion/Deletion in Gestational Diabetes Mellitus. AA genotype in the polymorphic loci IL-17A 197G>A rs2275913 causes a higher expression of IL-17, while the 14pb insertion in the 3′UTR in the HLA-G gene destabilizes mRNA causing a reduction in the expression of immunomodulatory HLA-G. This scenario increases the inflammatory profile characteristic of gestational diabetes mellitus with increased release of Th1/Th17 cytokines. Created in https://BioRender.com (accessed on 8 February 2025).

Similar articles

References

    1. Plows J.F., Stanley J.L., Baker P.N., Reynolds C.M., Vickers M.H. The Pathophysiology of Gestational Diabetes Mellitus. Int. J. Mol. Sci. 2018;19:3342. doi: 10.3390/ijms19113342. - DOI - PMC - PubMed
    1. Choudhury A.A., Devi Rajeswari V. Gestational diabetes mellitus—A metabolic and reproductive disorder. Biomed Pharmacother. 2021;143:112183. doi: 10.1016/j.biopha.2021.112183. - DOI - PubMed
    1. Mocellin L.P., Gomes H.A., Sona L., Giacomini G.M., Pizzuti E.P., Nunes G.B., Zanchet T.M., Macedo J.L. Gestational diabetes mellitus prevalence in Brazil: A systematic review and meta-analysis. Cad. Saude Publica. 2024;40:e00064919. - PMC - PubMed
    1. Oztekin O. New insights into the pathophysiology of gestational diabetes mellitus: Possible role of human leukocyte antigen-G. Med. Hypotheses. 2007;69:526–530. doi: 10.1016/j.mehy.2007.01.054. - DOI - PubMed
    1. Gomes Fagundes D.L., França E.L., da Silva Fernandes R.T., Hara Cde C., Morceli G., Honorio-França A.C., Calderon Ide M. Changes in T-cell phenotype and cytokines profile in maternal blood, cord blood and colostrum of diabetic mothers. J. Matern. Fetal Neonatal Med. 2016;29:998–1004. doi: 10.3109/14767058.2015.1031739. - DOI - PubMed

LinkOut - more resources